FAILED
首站-论文投稿智能助手
典型文献
Sanguinarine suppresses cell proliferation,migration and invasion in nasopharyngeal carcinoma via inhibiting mTOR signaling
文献摘要:
OBJECTIVE:To confirm the anti-NPC effect of sanguinarine(SA)through a series of wet experiments.METHODS:NPC cell viability was determined by proliferation experiment.Cell clone formation experiment,cell scratch test,transwell migration and invasion experiment and flow cytometry-based cell apoptosis assay were further performed.In addition,Western blotting was performed to investigate the cell signaling pathway.All the relevant experimental data were statistically processed using SPSS 16.0 software.RESULTS:The results showed that sanguinarine represented a time and dose dependent inhibition effects on NPC cell proliferation including the low differentiated CNE2 cells and high metastatic 5-8F cells,along with the cell cloning ability reduction.In addition,sanguinarine has a certain inhibitory effect on the invasion and migration of NPC cells.Mechanistically,sanguinarine displayed the anti-NPC effects mainly involved into the suppression of mTOR signaling and cell apoptosis,which is closely associated with the tumor growth and metastatic malignancy.CONCLUSIONS:Collectively,we discover that sanguinarine is a new high-efficiency anti-NPC monomer of Chinese medicine,with a value for the follow-up pre-clinical research.
文献关键词:
作者姓名:
YANG Mengzhe;ZHANG Beibei;LIANG Zhenqiang;CHENG Nannan;Lü Anqiao;YANG Jianyu;GUO Xingzhe;BAI Xianyu;HUANG Yuanjiao;JIAO Aijun;XU Ning
作者机构:
School of Basic Medical Sciences,Guangxi Medical University,Nanning 530021,China;Institute of Biomedical Research,Yunnan University,Kunming 650500,China;Department of Otolaryngology-Head and Neck Surgery,the Affiliated Tumor Hospital of Guangxi Medical University,Nanning 530021,China;Life Science Institute,Guangxi Medical University,Nanning 530021,China;Pharmaceutical College,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the Fifth Affiliated Hospital of Guangxi Medical University,Nanning 530021,China
引用格式:
[1]YANG Mengzhe;ZHANG Beibei;LIANG Zhenqiang;CHENG Nannan;Lü Anqiao;YANG Jianyu;GUO Xingzhe;BAI Xianyu;HUANG Yuanjiao;JIAO Aijun;XU Ning-.Sanguinarine suppresses cell proliferation,migration and invasion in nasopharyngeal carcinoma via inhibiting mTOR signaling)[J].中医杂志(英文版),2022(05):687-692
A类:
Sanguinarine,sanguinarine
B类:
suppresses,proliferation,migration,invasion,nasopharyngeal,carcinoma,inhibiting,mTOR,signaling,OBJECTIVE,To,confirm,anti,NPC,SA,through,series,wet,experiments,METHODS,viability,was,determined,by,Cell,clone,formation,scratch,test,transwell,flow,cytometry,apoptosis,assay,were,further,performed,In,addition,blotting,investigate,pathway,All,relevant,experimental,data,statistically,processed,using,software,RESULTS,results,showed,that,represented,dose,dependent,inhibition,effects,including,differentiated,CNE2,cells,high,metastatic,8F,along,cloning,reduction,has,certain,inhibitory,Mechanistically,displayed,mainly,involved,into,suppression,which,closely,associated,tumor,growth,malignancy,CONCLUSIONS,Collectively,discover,new,efficiency,monomer,Chinese,medicine,value,follow,clinical,research
AB值:
0.580369
相似文献
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。